SAN DIEGO, Sept. 30, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD), the world's leading health technology company focused on sleep, breathing, and care delivered in the home, today announced a ResMed first in CPAP (continuous positive airway pressure) mask innovation with the launch of the AirTouch™ N30i. Designed to create a natural and comfortable sleep experience for users, the AirTouch N30i is a fabric-wrapped frame featuring a soft, breathable, and moisture-wicking design for optimal comfort in ...

文章核心观点 - 公司推出了新的患者参与功能,以帮助睡眠呼吸暂停患者更好地管理自己的睡眠健康和持续正压通气(CPAP)治疗 [1][3][4] - 公司推出了一款基于生成式AI的睡眠健康助手,为用户提供个性化指导和实时信息 [6] - 公司推出了一系列专为CPAP用户设计的高端出行装备,帮助他们在旅行时也能保持治疗 [6][7] 关键要点总结 新的患者参与功能 - 推出了可在Apple和Android智能手表上使用的myAir应用程序,让用户可以随时查看治疗数据 [4] - 整合了来自Apple Health和Health Connect的睡眠阶段数据,让用户更好地了解自己的整个睡眠周期 [4] - 提供基于行为科学和机器学习的个性化指导和建议,帮助用户保持CPAP治疗 [4] - 提供全面的健康趋势数据,包括步数、能量消耗、体重、血氧、BMI、每日锻炼、心率变异性、静息心率、入睡时间和总睡眠时间等 [4] 睡眠健康助手Dawn - 提供24/7即时访问,回答有关睡眠呼吸暂停、公司产品和CPAP治疗支持的问题 [6] - 使用生成式AI提供个性化指导,实时连接用户所需的信息 [6] 出行装备LUXE - 针对经常出差的用户推出了时尚实用的旅行包 [7] - 包含模块化插件,可安全携带AirSense 10/11或AirMini、面罩、管路和电源 [7] - 可在公司网站和天猫平台购买 [7]

ResMed Inc (NYSE: RMD ) managed to deliver double-digit revenue and profit growths over the past 9 years despite being in a sector with single-digit revenue growth. This was because of its continuous acquisitions. BSc (Eng), MBA. Self-taught value investor with 2 decades of investing experience. Blogger at i4value.asia. The blog is on value investing through case studies where I analyze and value listed companies in the ASEAN and US regions. I have an exceptional perspective having served as a Board member ...

Key Takeaways The S&P 500 ended 0.3% lower on Wednesday, Sept. 18, as the Federal Reserve announced its first interest-rate cut since March 2020. ResMed shares tumbled after analysts said the likely label expansion of popular weight-loss drugs to treat sleep apnea could hurt demand for the company's devices. General Motors stock increased as the carmaker introduced adapters allowing drivers to power up GM EVs using Tesla's charging station network. Major U.S. equities indexes ended lower on Wednesday after ...

A looming threat from a very powerful rival could significantly dampen a key business for the company. Healthcare technology company ResMed's (RMD -5.12%) stock wasn't quite the picture of health on Wednesday. The shares lost more than 5% of their value on news of an analyst's downgrade and his new, bearish outlook. That performance didn't look good against that of the S&P 500 index, which fell a comparatively light 0.3%. A change in recommendation for the worse Well before market open that day, Wolfe Resea ...

Join iREIT on Alpha today to get the most in-depth research that includes REITs, mREITs, Preferreds, BDCs, MLPs, ETFs, and other income alternatives. 438 testimonials and most are 5 stars. Nothing to lose with our FREE 2-week trial . It's time to revisit a company I haven't covered in quite a while. As the title of this article gave away, that company is ResMed (NYSE: RMD ) , a fast-growing healthcare company. Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the comp ...

ResMed Inc.'s (RMD) growth is backed by its impressive global Mask sales growth. Of late, the company has been experiencing increased Device sales, reflecting the ongoing combined availability of AirSense 10 and AirSense 11 sleep devices. However, concerns loom over ResMed's escalating debt level and the adverse impact of macroeconomic challenges. In the past year, this Zacks Rank #3 (Hold) company's shares have surged 66.9% compared with 16.9% growth of the industry. The S&P 500 composite rose 21.1% during ...

Learn more about ResMed's 2030 strategy to accelerate growth Join in person or via virtual webcast SAN DIEGO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) will host an investor day on Monday, September 30, 2024, beginning at approximately 1:00 p.m. (Eastern Daylight Time). As previously announced, the event will be held at the New York Stock Exchange in New York City and simultaneously webcast online. More information about this event, including access to the live webcast link (available ...

SAN DIEGO, Aug. 28, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, Chairman and Chief Executive Officer, and Dr. Carlos Nunez, Chief Medical Officer, will participate in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4, 2024, beginning at approximately 10:00 a.m. (Eastern Daylight Time) at the New York Marriott Marquis in New York, NY. More information about this event, including access to the live, audio-only webca ...

Key Takeaways The S&P 500 added 0.2% on Tuesday, Aug. 27, ahead of Nvidia's earnings report on Wednesday and key economic data on tap for later in the week. ResMed shares soared amid an upbeat outlook for sleep apnea treatments, while Insulet shares jumped following a new FDA approval. Shares of Paramount Global fell after media executive Edgar Bronfman Jr. withdrew a bid to acquire the company. Major U.S. equities indexes ticked higher ahead of a potentially consequential earnings report from semiconductor ...